13D Filing: Levin Capital Strategies and Fluidigm Corp (FLDM)

Page 14 of 21

Page 14 of 21 – SEC Filing

(c) The transactions in the Shares by Trilogy during the past 60 days are set forth in Schedule A and are incorporated herein by
reference.

D. LCSL

(a)  As
the General Partner of Trilogy, LCSL is deemed to beneficially own the 82,884 Shares beneficially owned by Trilogy.

Percentage: Less than 1.0%.

(b) 1. Sole power to vote or direct vote: 0

2. Shared power to vote or direct vote:
82,884 *

3. Sole power to dispose or direct
the disposition: 0

4. Shared power to dispose or direct
the disposition: 82,884 *

* As the general partner to Trilogy, LCSL has shared
voting and dispositive power over these Shares. As the investment advisor to Trilogy, LCS has shared voting and dispositive power
over these Shares.

(c) LCSL has not undertaken any transactions in the Shares during the past 60 days. The transactions in the Shares by Trilogy during
the past 60 days are set forth in Schedule A and are incorporated herein by reference.

E. Levcap

(a)  As
of the close of business on August 10, 2017, Levcap beneficially owned 22,453 Shares.

Percentage: Less than 1.0%.

(b) 1. Sole power to vote or direct vote: 0

2. Shared power to vote or direct vote:
56,820 *

3. Sole power to dispose or direct
the disposition: 0

4. Shared power to dispose or direct
the disposition: 56,820*

* As the general partner to Levcap, LCSEP has shared
voting and dispositive power over these Shares. As the investment advisor to Levcap, LCS has shared voting and dispositive power
over these Shares.

(c) The transactions in the Shares by Levcap during the past 60 days are set forth in Schedule A and are incorporated herein by
reference.
14

Follow Standard Biotools Inc. (NASDAQ:LAB)

Page 14 of 21